subscribeSubscribe
Enforcement Report - Week of June 5, 2024

Enforcement Report - Week of June 5, 2024
FDA
05 Jun 2024
Share Share
Hong Kong`s Generic Zoledronic Acid Receives Approval in the U.S.

Hong Kong`s Generic Zoledronic Acid Receives Approval in the U.S.
FDA
05 Jun 2023
Share Share
Poseida Therapeutics Provides Updates and Financial Results for the 2Q of 2022

Poseida Therapeutics Provides Updates and Financial Results for the 2Q of 2022
PRNEWSWIRE
11 Aug 2022
Share Share
Health Canada Issues Recall of Taro Pharma`s Zoledronic Acid

Health Canada Issues Recall of Taro Pharma`s Zoledronic Acid
HEALTH CANADA
10 Aug 2022
Share Share
Common osteoporosis treatments could reduce incidence of COVID-19

Common osteoporosis treatments could reduce incidence of COVID-19
Victoria Rees EUROPEANPHARMACEUTICALREVIEW
04 Nov 2020
Share Share
Health Canada Issues Recall of Taro Pharmaceuticals`s Zoledronic Acid

Health Canada Issues Recall of Taro Pharmaceuticals`s Zoledronic Acid
HEALTH CANADA
02 Apr 2020
Share Share
Gland Pharma`s Generic Zoledronic Acid Receives Approval in US

Gland Pharma`s Generic Zoledronic Acid Receives Approval in US
FDA
13 Aug 2019
Share Share
Shilpa Medicare`s Generic Zoledronic Acid Receives Approval in US

Shilpa Medicare`s Generic Zoledronic Acid Receives Approval in US

FDA
20 May 2019
Share Share
Gland Pharma`s Generic Zoledronic Acid Receives Tentative Approval in US

Gland Pharma`s Generic Zoledronic Acid Receives Tentative Approval in US
FDA
25 Apr 2019
Share Share
Investigation of generic ‘cartel’ expands to 300 drugs

Investigation of generic ‘cartel’ expands to 300 drugs
Christopher Rowland WASHINGTON POST
09 Dec 2018
Share Share